Login / Signup

Long-term safety of the stem cell releasing compound plerixafor for peripheral stem cell collection in myeloma patients.

Melanie MaechlerVera Ulrike BacherMichael DaskalakisHenning NiliusMichael NaglerBehrouz Mansouri TaleghaniBarbara JekerThomas Pabst
Published in: Hematological oncology (2022)
Keyphrases
  • stem cells
  • newly diagnosed
  • end stage renal disease
  • ejection fraction
  • chronic kidney disease
  • peritoneal dialysis
  • prognostic factors
  • patient reported outcomes
  • bone marrow
  • patient reported
  • chemotherapy induced